2015 CLB Forum: Hormones and the Aging Brain

San Diego, CA US

This yearly forum highlights the collaboration between industry, academia, and healthcare agencies from both government and non-government organizations in approaches to treatment of endocrine disorders. Enhance your ENDO 2015 experience with this special breakfast symposium. Speakers representing clinical science and industry will provide perspectives on regulation and function of hormones on the aging brain.

Target Audience

This educational activity should be of substantial interest to basic and clinical endocrinologists, endocrine fellows, and healthcare professionals who treat patients with endocrine disorders.

Learning Objectives

Upon completion of this educational activity, participants will be better able to:

  • Understand the differences in risk factors for dementia in men and women
  • Describe how sex hormones and gender differentially impact the risk for dementia and Alzheimer Disease
  • List potential factors responsible for the observed greater prevalence of dementia in women and scope of the problem
  • Recognize the strong association between diabetes and the development of dementia
  • Explain potential pathophysiological mechanisms underlying the relationship of Type 2 Diabetes and Alzheimer Disease
  • Identify potential novel drug development approaches for the treatment of Alzheimer Disease
  • Suggest strategies for collaboration among academia, government, and industry in translational research for therapies in Alzheimer Disease

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Quality Improvement and Healthcare Delivery
General Endocrinology
Hormones and Cancer
Neuroendocrinology and Pituitary
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Course opens: 
Course expires: 
Hilton San Diego Bayfront
1 Park Boulevard
San Diego, CA 92101
United States

John Germak, MD – Program Director
Senior Director, Clinical Development and Medical Affairs Biopharmaceuticals
Novo Nordisk Inc.
Plainsboro, New Jersey

Walter A. Rocca, MD, MPH
Ralph S. and Beverly E. Caulkins Professor of Neurodegenerative Disease Research
Professor of Epidemiology and Neurology
Department of Health Sciences Research
Department of Neurology
Mayo Clinic
Rochester, Minnesota

Gail Musen, PhD
Assistant Professor of Psychiatry
Joslin Diabetes Center/Harvard Medical College
Boston, Massachusetts

Steven E. Arnold, MD
Professor of Psychiatry and Neurology
Director, Penn Memory Center and Clinical Core
University of Pennsylvania Alzheimer’s Disease Center
Director, Geriatric Psychiatry Section
Associate Director, Institute on Aging
Philadelphia, Pennsylvania


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the education content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent education planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:
John Germak, MD: Employee, Novo Nordisk Inc.

The following faculty reported no relevant financial relationships: Steven Arnold, MD;  Gail Musen. PhD; Walter A. Rocca, MD, MPH

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.